Vident Advisory’s Hologic HOLX Stock Holding History

Vident Advisory’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,096	Closed	-$763K	–	1983
2026 Q1	$763K	Sell	10,096 -54,709	-84%	-$4.11M	0.01%	1003
2025 Q4	$4.83M	Buy	64,805 +15,654	+32%	+$1.14M	0.04%	338
2025 Q3	$3.32M	Buy	49,151 +41,068	+508%	+$2.73M	0.03%	413
2025 Q2	$527K	Sell	8,083 -12,850	-61%	-$770K	0.01%	1018
2025 Q1	$1.29M	Buy	20,933 +15,063	+257%	+$998K	0.02%	628
2024 Q4	$423K	Buy	5,870 +86	+1%	+$6.72K	0.01%	1037
2024 Q3	$471K	Sell	5,784 -1,542	-21%	-$123K	0.01%	951
2024 Q2	$544K	Sell	7,326 -919	-11%	-$68.9K	0.02%	836
2024 Q1	$643K	Sell	8,245 -7,945	-49%	-$591K	0.01%	718
2023 Q4	$1.16M	Sell	16,190 -76	-0.5%	-$5.29K	0.03%	519
2023 Q3	$1.13M	Buy	+16,266	New	+$1.23M	0.04%	473

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vident Advisory's HOLX Position: Q2 2026 in Review

Vident Advisory sold out of Hologic (HOLX) in Q2 2026, closing a stake of 10,096 shares — an estimated $763K sold.

Vident Advisory first reported a position in HOLX in Q3 2023 and held it in 11 quarters. The position peaked at $4.83M in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Vident Advisory reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Vident Advisory sold 10,096 Hologic shares in Q2 2026, an estimated $763K.
Vident Advisory first reported a position in Hologic in Q3 2023 and held it in 11 quarters.
Vident Advisory's Hologic position peaked at $4.83M in Q4 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.